Insight Molecular Diagnostics Inc.
IMDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9 | $9 | $20 | $33 |
| Short-Term Investments | $0 | $0 | $0 | $1 |
| Receivables | $2 | $0 | $2 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $3 | $4 |
| Total Curr. Assets | $12 | $11 | $26 | $39 |
| Property Plant & Equip (Net) | $3 | $5 | $11 | $8 |
| Goodwill | $0 | $0 | $0 | $19 |
| Intangibles | $15 | $57 | $62 | $62 |
| Long-Term Investments | $2 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $4 | $2 | $2 | $32 |
| Total NC Assets | $23 | $64 | $75 | $120 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $35 | $75 | $100 | $160 |
| Liabilities | – | – | – | – |
| Payables | $2 | $1 | $1 | $2 |
| Short-Term Debt | $1 | $1 | $1 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $6 | $10 | $10 |
| Total Curr. Liab. | $7 | $7 | $12 | $14 |
| LT Debt | $2 | $2 | $3 | $4 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $38 | $45 | $46 | $77 |
| Total NC Liab. | $40 | $47 | $48 | $80 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $3 | $4 | $4 |
| Total Liabilities | $47 | $54 | $60 | $94 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $5 | $0 |
| Common Stock | $338 | $310 | $295 | $253 |
| Retained Earnings | -$351 | -$290 | -$261 | -$188 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | -$0 | $0 |
| Total Equity | -$12 | $20 | $40 | $65 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $35 | $75 | $100 | $160 |
| Net Debt | -$5 | -$7 | -$16 | -$27 |